NASDAQ · Financial Statements

CapsoVision, Inc. (CV) Financial Statements

$6.60 NASDAQ: CV Market Cap $329.76M

CapsoVision, Inc. most recently reported annual revenue of $14.0M, net profit of $-25.0M, revenue has compounded at 18.3% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric202320242025
Revenue$10.0M$12.0M$14.0M
Operating Profit$-11.0M$-20.0M$-26.0M
Net Profit$-11.0M$-20.0M$-25.0M
EPS$-0.29$-0.43$-0.54
Op Margin-116.3%-169.4%-188.3%

Balance Sheet (USD)

Metric202320242025
Total Assets$22.0M$17.0M$18.0M
Total Liabilities$131.0M$146.0M$5.0M
Cash$15.0M$9.0M$10.0M
Borrowings$2.0M$1.0M$1.0M

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$-11.0M$-20.0M$-23.0M
Investing Cash Flow$-2.0M$0$0
Financing Cash Flow$0$0$-3.0M
Net Cash Flow$9.0M$-5.0M$1.0M
Free Cash Flow$-12.0M$-20.0M$-23.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.34
EV / EBITDA-10.13
FCF Yield-9.05%
Quick Ratio2.44
Interest Coverage0.00
Return 1Y55.29%
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
CV Overview CV Dividend Run Stock Screener